PW01-022 – Dissociation between CRP and SAA in FMF

274 samples from 219 patients were analysed. The cohort had a median age of 24 years old [interquartile 15-35], 54% were female. Ethnic origins were: 60% non-ashkenasi Jews, 1% ashkenasi Jews, 4% mixed, 9.5% Arabs, 5% Armenians, 5% Turks, 3% Lebanese or Syrians, 1% Italians, 1% Portuguese or Spanish, 1% Caucasian. MEFV genotype was known in 181 patients (83%): 63.5% had 2 non-ambiguous mutations, 24% were simple heterozygous, 7% were compound heterozygous with one non-ambiguous mutation and one polymorphism, 5.5% had no mutation. Six patients had amyloidosis. 181 patients (83%) were treated with colchicine, 3 patients with interleukin-1 inhibitor. Elevated SAA (median=16.5mg/L [13;31] while normal CRP was found in 21 samples (13% samples of with normal CRP). Elevated CRP (median=9mg/L [7;11]) while normal SAA was found in 38 samples (22% samples of normal SAA). Age was significantly higher in group B comparing to group A or the group with no dissociation (33 years old versus 21 and 23 respectively, p=0.004). Colchicine dosage was significantly higher in group B comparing to the group with no dissociation (1.05mg/day versus 1.34, p=0.04). No statistical difference was found concerning genotype or Ethnic origin. Dissociation with high SAA and normal CRP was found in some patients with amyloidosis but the difference was not statistically different (p=0.08). Finally, for values of CRP above 30mg/L (30-63mg/L), corresponding SAA values were 1.5 to 6 times higher (53-683).